NeOnc posts Q3 results, confirms positive Phase 2a data for NEO100 ahead of SNO
The company reported a narrower net loss, a $15 million raise and preferred stock redemption, and said updated NEO100 and NEO212 data will be shown at SNO on November 13.
SEC filing (2)